Developer docs
API playgroundTry for free, no card

Search company profiles

MangoRx

Full company profile

uuid0002kgw

Namestring
MangoRx
Legal namestring
Mangoceuticals, Inc.
Websiteurl
mangorx.com
Company typeenum
Public
Founded yearint
2021
Descriptiontext

MangoRx, operated by Mangoceuticals, Inc. (NASDAQ: MGRX), is a Dallas-based direct-to-consumer telehealth platform serving U.S. men with prescription treatments for erectile dysfunction, testosterone replacement, hair loss, weight management, and athletic performance. The company connects patients with licensed U.S. medical providers via a 100% online questionnaire-to-delivery flow, with prescriptions fulfilled by a Texas-based partner compounding pharmacy holding URAC, ACHC-PCAB, and LegitScript credentials, and shipped discreetly via UPS. Its proprietary technology stack is built around oral dissolving tablet (ODT) delivery—a sublingual format that achieves onset in as little as 10 minutes versus up to an hour for traditional pills—combined with novel multi-ingredient compounded formulations such as MangoMax (Sildenafil+Tadalafil+Oxytocin+Naltrexone), Pump (Tadalafil+Agmatine Sulfate), Grow (Minoxidil+Finasteride+Biotin+D3), and Slim (Semaglutide+Vitamin B6).

The business model is predominantly subscription/recurring revenue, anchored by the $99/month all-inclusive injectable TRT program launched in December 2025 (reported 336% MoM sales growth) and the $499/month GLP-1 obesity program (MangoRx Direct/PeachesRx Direct) launched November 2025 via access to LillyDirect and NovoCare channels. Per-tablet products (ED at $12.50, Pump at $2.50, Grow at $3.00) are sold through the proprietary e-commerce site with Subscribe and Save auto-refills at 10% discount. Free provider visits, no insurance requirement, and no mandatory subscription lower customer friction. The company also operates a wholly-owned subsidiary Mango DAT, LLC managing a Solana-focused Digital Asset Treasury strategy of up to $100M, and holds a PCT patent filing for MGX-0024 antiviral animal feed technology developed with IntraMont Technologies.

Operationally, the company remains small (1-10 employees), reported Q3 2023 revenue of $361,661 (29% YoY decline) with $17.9M in net losses, and has raised approximately $3.7M cumulatively across two post-IPO offerings in December 2023 ($1.2M) and December 2025 ($2.5M). It is engaged in a $73M lawsuit against former technology vendor Clarity Ventures, following disengagement and in-house platform development.

Short descriptiontext

MangoRx is a Dallas-based direct-to-consumer telehealth platform that connects U.S. men with licensed providers for prescription compounded oral dissolving tablet treatments for erectile dysfunction, testosterone replacement, hair loss, weight loss, and performance enhancement.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
men's telehealth services, erectile dysfunction treatment, testosterone replacement therapy, hair loss treatment, weight management medications
Industry3 codes
PRIMARYHLALAIAA
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAIAJ
Men’s Health Prescribing + Pharmacy Delivery Platforms
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAAAD
Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
NAICS code2 codes
  • Offices of Other Health Practitioners6213
  • Pharmaceutical and Medicine Manufacturing3254
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Men's Telehealth
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model7 records
1Testosterone Replacement Therapy (TRT) Program
TypeSubscription Recurring
Description

All-inclusive injectable Testosterone Replacement Therapy program priced at $99 per month, generating monthly recurring revenue per customer. Launched mid-December with 336% month-over-month sales growth reported. Company expects TRT to be its primary growth driver.

ng.investing.com
2Erectile Dysfunction Medications (Mango – Sildenafil, Tadalafil, MangoMax)
TypeSubscription Recurring
Description

Individual ED tablets sold at $12.50 per tablet in packs of 6, 12, or 18. Optional Subscribe and Save provides 10% discount and auto-refills processed every 25 days. MangoMax combines Tadalafil and Sildenafil in one formula.

mangorx.com
3Pump (Tadalafil + Agmatine Sulfate)
TypeSubscription Recurring
Description

Pre-workout/performance product sold at $2.50 per tablet, available in 30-day, 60-day, or 90-day supply packs. Subscribe and Save provides 10% discount on initial and all subsequent auto-refill orders.

mangorx.com
4Grow Hair Loss Treatment
TypeSubscription Recurring
Description

Hair growth chewable tablets at $3 per tablet, with 30-day, 60-day, or 90-day supply options. Subscribe and Save includes free UPS Ground shipping and 10% discount on auto-refill orders.

mangorx.com
5Slim Weight Loss (Semaglutide ODT)
TypeSubscription Recurring
Description

Oral dissolving Semaglutide tablets for weight management. No explicit per-tablet price listed publicly; consultation at $99/month with personalized care plans.

mangorx.com
6GLP-1 Weight Management Programs (MangoRx Direct & PeachesRx Direct)
TypeSubscription Recurring
Description

Access to branded GLP-1 medications (Zepbound, Wegovy) at $499/month starting price plus $99/month membership fee, with no insurance required. Prescriptions facilitated through a third-party provider.

globenewswire.com
7Digital Asset Treasury Strategy
TypeManaged Services
Description

Mangoceuticals launched Mango DAT, LLC as a newly formed subsidiary partnering with Cube Group to manage an up to $100 million Solana-focused Digital Asset Treasury strategy with target yields of 7-8% APY on staked SOL.

stocktitan.net
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Marketing or Sales, Supply Chain, Technology or R&D, Personnel, Operations
Pricing details7 tiers
1TRT Program — $99/month all-inclusive injectable Testosterone Replacement Therapy
ModelSubscriptionBilling cadenceMonthly
Notes

$99 per month all-inclusive injectable Testosterone Replacement Therapy. Launched mid-December; 336% month-over-month sales growth. Expected to be primary growth driver. Bloodwork not included; SpotDX kit $75 or Tasso+ kit $100.

ng.investing.com
2ED Medications — Mango Sildenafil/Tadalafil at $12.50/tablet
ModelSubscriptionBilling cadenceMonthly
Notes

$12.50 per tablet for Sildenafil Mango and Tadalafil Mango; tablets sold in packs of 6, 12, or 18. Subscribe and Save: 10% off initial order + all subsequent auto-refill orders. Auto-refills processed every 25 days.

mangorx.com
3MangoMax — Dual-action ED at $75/pack starting
ModelUnit PricingBilling cadenceMonthly
Notes

Starting at $75 for MangoMax (combines Tadalafil 20mg + Sildenafil 80mg + Oxytocin 100 IU + Naltrexone 1.5mg). Works in as little as 10 minutes.

mangorx.com
4Pump — Tadalafil + Agmatine at $2.50/tablet
ModelSubscriptionBilling cadenceMonthly
Notes

$2.50 per tablet for Pump (Tadalafil + Agmatine Sulfate); available in 30-day, 60-day, or 90-day supply packs. Subscribe and Save: 10% off + free shipping on auto-refills processed every 25 days.

mangorx.com
5Grow Hair Loss — $3/tablet, starting $90/30-day supply
ModelSubscriptionBilling cadenceMonthly
Notes

$3 per tablet for Grow (Minoxidil 2.5mg + Finasteride 1mg + Biotin 1mg + D3 2000 IU); available in 30-day, 60-day, or 90-day supply packs. Subscribe and Save: free UPS Ground shipping + 10% off auto-refills every 25 days.

mangorx.com
6Slim Weight Loss — Semaglutide ODT at $99/month consultation
ModelSubscriptionBilling cadenceMonthly
Notes

Slim (Semaglutide 1-6mg + Vitamin B6 oral dissolving tablet) — consultation $99/month with personalized care plans and ongoing support. No explicit per-tablet price disclosed publicly.

mangorx.com
7MangoRx Direct & PeachesRx Direct GLP-1 Programs — $499/month + $99 membership
ModelSubscriptionBilling cadenceMonthly
Notes

$499/month starting price for GLP-1 medications (Eli Lilly's Zepbound and Novo Nordisk's Wegovy) plus $99/month membership fee. No insurance required. No direct contractual relationship with Eli Lilly or Novo Nordisk.

globenewswire.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 9 records shown
1MangoMax
Description

ED treatment combining Sildenafil and Tadalafil for both fast-acting and long-lasting performance with Oxytocin and Naltrexone

mangorx.com
+8 more records
Core offering1 text field

MangoRx operates a 100% online men's telehealth platform that connects individual male patients with licensed U.S. medical providers via online questionnaires and consultations, then dispenses personalized compounded prescription medications through an in-network pharmacy shipped directly to the patient's home. The product portfolio centers on proprietary oral dissolving tablet (ODT) formulations across erectile dysfunction, testosterone replacement, hair loss, weight management, and athletic performance, supplemented by telehealth-mediated access to branded GLP-1 medications (Zepbound, Wegovy).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 336% month-over-month sales growth for injectable TRT program since mid-December launch
+6 more records
Product overview1 text field

MangoRx is a men's health telehealth platform operating as a single unified offering with multiple treatment modules. The platform connects patients with licensed healthcare providers via online consultations and ships prescription medications from a certified partner pharmacy. The product portfolio spans five core treatment categories: (1) Erectile dysfunction treatments comprising MangoMax (Sildenafil+Tadalafil combination), Mango Sildenafil, and Mango Tadalafil as oral dissolving tablets; (2) Testosterone Replacement Therapy (TRT) as an injectable program; (3) Hair loss treatment via Grow chewable tablets; (4) Weight management through Slim oral dissolving tablets with Semaglutide; and (5) Performance enhancement via Pump tablets. Additionally, MangoRx Direct and PeachesRx Direct programs provide access to branded GLP-1 medications (Zepbound and Wegovy) sourced from Eli Lilly and Novo Nordisk respectively.

Product and service9 records
1MangoMax
CategoryErectile dysfunction treatment
Description

Oral dissolving tablet for erectile dysfunction combining Tadalafil and Sildenafil with Oxytocin and Naltrexone, designed to activate in as little as 10 minutes and provide both fast-acting and long-lasting performance for adult men.

2Mango Sildenafil
CategoryErectile dysfunction treatment
Description

Sublingual oral dissolving tablet combining Sildenafil with Oxytocin and L-Arginine for erectile dysfunction, available in 50mg or 100mg dosages; activates in approximately 10 minutes with effects lasting up to 4 hours.

3Mango Tadalafil
CategoryErectile dysfunction treatment
Description

Sublingual oral dissolving tablet combining Tadalafil with Oxytocin and L-Arginine for erectile dysfunction, available in 10mg or 20mg dosages; provides long-lasting effects up to 36 hours.

4Testosterone Replacement Therapy (TRT) Program
CategoryTestosterone replacement therapy
Description

$99/month all-inclusive injectable testosterone replacement therapy subscription including physician review, blood panel assessment, and ongoing monitoring for men with low testosterone.

5Grow
CategoryHair loss treatment
Description

Daily chewable mint-flavored tablet for male pattern baldness combining Minoxidil (2.5mg), Finasteride (1mg), Biotin (1mg), and Vitamin D3 (2000 IU); available in 30/60/90-day supply packs with Subscribe and Save 10% discount.

6Slim
CategoryWeight management
Description

Oral dissolving tablet containing compounded Semaglutide (1–6mg) with Vitamin B6 for daily weight management, providing a needle-free oral GLP-1 alternative that mimics GLP-1 hormones to reduce appetite and caloric intake.

7Pump
CategoryAthletic performance enhancement
Description

Daily oral dissolving tablet combining Tadalafil and Agmatine Sulfate for pre-workout performance, supporting nitric oxide signaling, healthy blood flow, muscle pumps, and recovery without caffeine-related jitters or crashes.

8MangoRx Direct
CategoryWeight management / GLP-1 access
Description

Telehealth subscription program providing access to FDA-approved branded GLP-1 medications (Eli Lilly's Zepbound) for obesity management, priced at $499/month starting plus $99/month membership fee, with no insurance required and fulfillment through partner pharmacy channels including LillyDirect.

9PeachesRx Direct
CategoryWeight management / GLP-1 access
Description

Telehealth weight management subscription program providing access to FDA-approved branded GLP-1 medications (Novo Nordisk's Wegovy) for obesity management, priced at $499/month starting plus $99/month membership fee, with no insurance required and fulfillment through partner pharmacy channels including NovoCare.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1IntraMont Technologies, Inc.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-26
Description

Mangoceuticals entered into a partnership with IntraMont Technologies, Inc. to co-develop the MGX-0024 antiviral animal feed and drinking water additive technology. A PCT international patent application was filed on February 26, 2026, to secure global IP protection. Field trials across 29,000 birds demonstrated zero respiratory-related mortality and statistically significant H5N1 protection.

stocktitan.net
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-11-13
Description

MangoRx Direct and PeachesRx Direct programs provide access to Eli Lilly's Zepbound (tirzepatide) GLP-1 medication for obesity management at $499/month starting price plus $99/month membership fee. No direct contractual relationship exists; prescriptions facilitated through a third-party provider and fulfillable at LillyDirect and other licensed pharmacies.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-11-13
Description

MangoRx Direct and PeachesRx Direct programs provide access to Novo Nordisk's Wegovy (semaglutide) GLP-1 medication for obesity management at $499/month starting price plus $99/month membership fee. No direct contractual relationship exists; prescriptions facilitated through a third-party provider and fulfillable at NovoCare and other licensed pharmacies.

Strategic tierMinorTypeOthers
Description

Clarity Ventures was a former technology consulting and software development firm engaged to build a HIPAA-compliant enterprise eCommerce platform. Mangoceuticals filed a $73 million lawsuit against Clarity Ventures alleging failure to deliver a compliant platform. Clarity denied allegations and asserted counterclaims. Mangoceuticals subsequently developed an in-house proprietary telehealth platform.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Epiq Scripts, LLC serves as the pharmacy partner for prescription fulfillment services through MangoRx's telehealth platform. MangoRx operates as a technology platform connecting users to prescription fulfillment services through Epiq Scripts.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

MangoRx offers LabCorp testing through the platform for in-person blood work visits required for testosterone support protocols. Bloodwork must include Total Testosterone, Free Testosterone, SHBG, PSA, FSH, and Estradiol panels within 30 days.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

MangoRx partners with SpotDX to provide an at-home dried blood sample kit for testosterone support blood panels at $75. Both options include all approved blood panels required for TRT protocols.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

MangoRx partners with Tasso+ to provide a capillary sample at-home blood kit for testosterone support protocols at $100 (preferred option). The Tasso+ kit provides all approved blood panels required for TRT protocols.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

DTC men's telehealth brand focused on hair loss treatment (Finasteride, Minoxidil). Directly comparable to MangoRx's Grow product line in both category and cash-pay model.

2Ro (Roman)
TypeDirect peer
Description

DTC men's telehealth platform historically focused on ED (Roman) and now spanning testosterone, hair, weight loss, and fertility. Directly comparable subscription model, condition-specific modules, and compounded offerings.

TypeBroad incumbent
Description

Largest US telehealth incumbent offering virtual care across many specialties. Overlaps MangoRx at the telehealth delivery mechanism and provider network layer, though MangoRx is more DTC-focused.

TypeEmerging player
Description

DTC telehealth company offering men's hormone therapy, weight management, and primary care with subscription programs. Comparable cash-pay telehealth model and category breadth.

TypeEmerging player
Description

DTC men's hormone optimization and TRT telehealth platform with at-home diagnostics. Directly comparable to MangoRx's TRT offering and similar subscription pricing model.

6GoodRx
TypeBroad incumbent
Description

Public digital health platform providing telehealth and prescription drug discounts. Broader incumbent that competes with MangoRx on cash-pay prescription affordability and online pharmacy access.

TypeEmerging player
Description

Telehealth platform offering testosterone replacement therapy and men's hormone optimization with at-home diagnostics. Closely comparable to MangoRx's TRT/Prime program with similar clinical workflow.

TypeEmerging player
Description

Men's telehealth brand offering ED, testosterone, and hair loss treatments via cash-pay subscription. Comparable niche DTC men's health positioning but smaller scale.

TypeDirect peer
Description

DTC telehealth platform specializing in compounded Sildenafil/Tadalafil chewable tablets for ED. Closely comparable business model and pharmacy-fulfillment approach to MangoRx's ED product line.

TypeDirect peer
Description

Largest direct-to-consumer telehealth platform for men's (and women's) health covering ED, hair loss, weight loss, and primary care. Closest direct competitor with public-comparable scale and a similar cash-pay subscription model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MangoRx

Men's Telehealthmangorx.com

MangoRx is a Dallas-based direct-to-consumer telehealth platform that connects U.S. men with licensed providers for prescription compounded oral dissolving tablet treatments for erectile dysfunction, testosterone replacement, hair loss, weight loss, and performance enhancement.

What MangoRx does

MangoRx, operated by Mangoceuticals, Inc. (NASDAQ: MGRX), is a Dallas-based direct-to-consumer telehealth platform serving U.S. men with prescription treatments for erectile dysfunction, testosterone replacement, hair loss, weight management, and athletic performance. The company connects patients with licensed U.S. medical providers via a 100% online questionnaire-to-delivery flow, with prescriptions fulfilled by a Texas-based partner compounding pharmacy holding URAC, ACHC-PCAB, and LegitScript credentials, and shipped discreetly via UPS. Its proprietary technology stack is built around oral dissolving tablet (ODT) delivery—a sublingual format that achieves onset in as little as 10 minutes versus up to an hour for traditional pills—combined with novel multi-ingredient compounded formulations such as MangoMax (Sildenafil+Tadalafil+Oxytocin+Naltrexone), Pump (Tadalafil+Agmatine Sulfate), Grow (Minoxidil+Finasteride+Biotin+D3), and Slim (Semaglutide+Vitamin B6).

The business model is predominantly subscription/recurring revenue, anchored by the $99/month all-inclusive injectable TRT program launched in December 2025 (reported 336% MoM sales growth) and the $499/month GLP-1 obesity program (MangoRx Direct/PeachesRx Direct) launched November 2025 via access to LillyDirect and NovoCare channels. Per-tablet products (ED at $12.50, Pump at $2.50, Grow at $3.00) are sold through the proprietary e-commerce site with Subscribe and Save auto-refills at 10% discount. Free provider visits, no insurance requirement, and no mandatory subscription lower customer friction. The company also operates a wholly-owned subsidiary Mango DAT, LLC managing a Solana-focused Digital Asset Treasury strategy of up to $100M, and holds a PCT patent filing for MGX-0024 antiviral animal feed technology developed with IntraMont Technologies.

Operationally, the company remains small (1-10 employees), reported Q3 2023 revenue of $361,661 (29% YoY decline) with $17.9M in net losses, and has raised approximately $3.7M cumulatively across two post-IPO offerings in December 2023 ($1.2M) and December 2025 ($2.5M). It is engaged in a $73M lawsuit against former technology vendor Clarity Ventures, following disengagement and in-house platform development.

MangoRx firmographics

Firmographics
Name
MangoRx
Legal name
Mangoceuticals, Inc.
Website
https://mangorx.com
Company type
Public
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
MangoRx is a Dallas-based direct-to-consumer telehealth platform that connects U.S. men with licensed providers for prescription compounded oral dissolving tablet treatments for erectile dysfunction, testosterone replacement, hair loss, weight loss, and performance enhancement.
Ownership category
akta.pro rank

MangoRx industry classification

Industry
Product category
Men's Telehealth
NAICS
Offices of Other Health Practitioners (6213), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLALAIAA
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAIAJ
Men’s Health Prescribing + Pharmacy Delivery Platforms
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAAAD
Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

Keywords

  • Men's telehealth services
  • Erectile dysfunction treatment
  • Testosterone replacement therapy
  • Hair loss treatment
  • Weight management medications

Where MangoRx is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MangoRx business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Marketing or Sales, Supply Chain, Technology or R&D, Personnel, Operations

Revenue model

  1. Testosterone Replacement Therapy (TRT) Program: All-inclusive injectable Testosterone Replacement Therapy program priced at $99 per month, generating monthly recurring revenue per customer. Launched mid-December with 336% month-over-month sales growth reported. Company expects TRT to be its primary growth driver.
  2. Erectile Dysfunction Medications (Mango – Sildenafil, Tadalafil, MangoMax): Individual ED tablets sold at $12.50 per tablet in packs of 6, 12, or 18. Optional Subscribe and Save provides 10% discount and auto-refills processed every 25 days. MangoMax combines Tadalafil and Sildenafil in one formula.
  3. Pump (Tadalafil + Agmatine Sulfate): Pre-workout/performance product sold at $2.50 per tablet, available in 30-day, 60-day, or 90-day supply packs. Subscribe and Save provides 10% discount on initial and all subsequent auto-refill orders.
  4. Grow Hair Loss Treatment: Hair growth chewable tablets at $3 per tablet, with 30-day, 60-day, or 90-day supply options. Subscribe and Save includes free UPS Ground shipping and 10% discount on auto-refill orders.
  5. Slim Weight Loss (Semaglutide ODT): Oral dissolving Semaglutide tablets for weight management. No explicit per-tablet price listed publicly; consultation at $99/month with personalized care plans.
  6. GLP-1 Weight Management Programs (MangoRx Direct & PeachesRx Direct): Access to branded GLP-1 medications (Zepbound, Wegovy) at $499/month starting price plus $99/month membership fee, with no insurance required. Prescriptions facilitated through a third-party provider.
  7. Digital Asset Treasury Strategy: Mangoceuticals launched Mango DAT, LLC as a newly formed subsidiary partnering with Cube Group to manage an up to $100 million Solana-focused Digital Asset Treasury strategy with target yields of 7-8% APY on staked SOL.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyTRT Program — $99/month all-inclusive injectable Testosterone Replacement Therapy
SubscriptionMonthlyED Medications — Mango Sildenafil/Tadalafil at $12.50/tablet
Unit PricingMonthlyMangoMax — Dual-action ED at $75/pack starting
SubscriptionMonthlyPump — Tadalafil + Agmatine at $2.50/tablet
SubscriptionMonthlyGrow Hair Loss — $3/tablet, starting $90/30-day supply
SubscriptionMonthlySlim Weight Loss — Semaglutide ODT at $99/month consultation
SubscriptionMonthlyMangoRx Direct & PeachesRx Direct GLP-1 Programs — $499/month + $99 membership

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

MangoRx product offering

Product offering

Core offering

MangoRx operates a 100% online men's telehealth platform that connects individual male patients with licensed U.S. medical providers via online questionnaires and consultations, then dispenses personalized compounded prescription medications through an in-network pharmacy shipped directly to the patient's home. The product portfolio centers on proprietary oral dissolving tablet (ODT) formulations across erectile dysfunction, testosterone replacement, hair loss, weight management, and athletic performance, supplemented by telehealth-mediated access to branded GLP-1 medications (Zepbound, Wegovy).

Product overview

MangoRx is a men's health telehealth platform operating as a single unified offering with multiple treatment modules. The platform connects patients with licensed healthcare providers via online consultations and ships prescription medications from a certified partner pharmacy. The product portfolio spans five core treatment categories: (1) Erectile dysfunction treatments comprising MangoMax (Sildenafil+Tadalafil combination), Mango Sildenafil, and Mango Tadalafil as oral dissolving tablets; (2) Testosterone Replacement Therapy (TRT) as an injectable program; (3) Hair loss treatment via Grow chewable tablets; (4) Weight management through Slim oral dissolving tablets with Semaglutide; and (5) Performance enhancement via Pump tablets. Additionally, MangoRx Direct and PeachesRx Direct programs provide access to branded GLP-1 medications (Zepbound and Wegovy) sourced from Eli Lilly and Novo Nordisk respectively.

Differentiator

Problem solved

Functional benefit

Brands

  • MangoMax: ED treatment combining Sildenafil and Tadalafil for both fast-acting and long-lasting performance with Oxytocin and Naltrexone
  • Mango Sildenafil
  • Mango Tadalafil
  • Grow
  • Pump
  • Slim
  • Prime
  • MangoRx Direct
  • PeachesRx Direct

Products and services

  • MangoMax Oral dissolving tablet for erectile dysfunction combining Tadalafil and Sildenafil with Oxytocin and Naltrexone, designed to activate in as little as 10 minutes and provide both fast-acting and long-lasting performance for adult men.
  • Mango Sildenafil Sublingual oral dissolving tablet combining Sildenafil with Oxytocin and L-Arginine for erectile dysfunction, available in 50mg or 100mg dosages; activates in approximately 10 minutes with effects lasting up to 4 hours.
  • Mango Tadalafil Sublingual oral dissolving tablet combining Tadalafil with Oxytocin and L-Arginine for erectile dysfunction, available in 10mg or 20mg dosages; provides long-lasting effects up to 36 hours.
  • Testosterone Replacement Therapy (TRT) Program $99/month all-inclusive injectable testosterone replacement therapy subscription including physician review, blood panel assessment, and ongoing monitoring for men with low testosterone.
  • Grow Daily chewable mint-flavored tablet for male pattern baldness combining Minoxidil (2.5mg), Finasteride (1mg), Biotin (1mg), and Vitamin D3 (2000 IU); available in 30/60/90-day supply packs with Subscribe and Save 10% discount.
  • Slim Oral dissolving tablet containing compounded Semaglutide (1–6mg) with Vitamin B6 for daily weight management, providing a needle-free oral GLP-1 alternative that mimics GLP-1 hormones to reduce appetite and caloric intake.
  • Pump Daily oral dissolving tablet combining Tadalafil and Agmatine Sulfate for pre-workout performance, supporting nitric oxide signaling, healthy blood flow, muscle pumps, and recovery without caffeine-related jitters or crashes.
  • MangoRx Direct Telehealth subscription program providing access to FDA-approved branded GLP-1 medications (Eli Lilly's Zepbound) for obesity management, priced at $499/month starting plus $99/month membership fee, with no insurance required and fulfillment through partner pharmacy channels including LillyDirect.
  • PeachesRx Direct Telehealth weight management subscription program providing access to FDA-approved branded GLP-1 medications (Novo Nordisk's Wegovy) for obesity management, priced at $499/month starting plus $99/month membership fee, with no insurance required and fulfillment through partner pharmacy channels including NovoCare.

Quantifiable outcome

  • 336% month-over-month sales growth for injectable TRT program since mid-December launch
  • +6 more outcomes

Companies that use MangoRx

Customer profile

Segments5 records

Ideal customer profiles5 records

MangoRx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

MangoRx partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • IntraMont Technologies, Inc.coreStrategic or Co-development Partner · 26 February 2026Mangoceuticals entered into a partnership with IntraMont Technologies, Inc. to co-develop the MGX-0024 antiviral animal feed and drinking water additive technology. A PCT international patent application was filed on February 26, 2026, to secure global IP protection. Field trials across 29,000 birds demonstrated zero respiratory-related mortality and statistically significant H5N1 protection.
  • Eli LillycoreChannel Partner/ Reseller/ Distributor · 13 November 2025MangoRx Direct and PeachesRx Direct programs provide access to Eli Lilly's Zepbound (tirzepatide) GLP-1 medication for obesity management at $499/month starting price plus $99/month membership fee. No direct contractual relationship exists; prescriptions facilitated through a third-party provider and fulfillable at LillyDirect and other licensed pharmacies.
  • Novo NordiskcoreChannel Partner/ Reseller/ Distributor · 13 November 2025MangoRx Direct and PeachesRx Direct programs provide access to Novo Nordisk's Wegovy (semaglutide) GLP-1 medication for obesity management at $499/month starting price plus $99/month membership fee. No direct contractual relationship exists; prescriptions facilitated through a third-party provider and fulfillable at NovoCare and other licensed pharmacies.
  • Clarity VenturesminorOthersClarity Ventures was a former technology consulting and software development firm engaged to build a HIPAA-compliant enterprise eCommerce platform. Mangoceuticals filed a $73 million lawsuit against Clarity Ventures alleging failure to deliver a compliant platform. Clarity denied allegations and asserted counterclaims. Mangoceuticals subsequently developed an in-house proprietary telehealth platform.
  • Epiq Scripts, LLCcoreImplementation/ SI/ Consulting PartnerEpiq Scripts, LLC serves as the pharmacy partner for prescription fulfillment services through MangoRx's telehealth platform. MangoRx operates as a technology platform connecting users to prescription fulfillment services through Epiq Scripts.
  • LabCorpminorChannel Partner/ Reseller/ DistributorMangoRx offers LabCorp testing through the platform for in-person blood work visits required for testosterone support protocols. Bloodwork must include Total Testosterone, Free Testosterone, SHBG, PSA, FSH, and Estradiol panels within 30 days.
  • SpotDXminorChannel Partner/ Reseller/ DistributorMangoRx partners with SpotDX to provide an at-home dried blood sample kit for testosterone support blood panels at $75. Both options include all approved blood panels required for TRT protocols.
  • Tasso+minorChannel Partner/ Reseller/ DistributorMangoRx partners with Tasso+ to provide a capillary sample at-home blood kit for testosterone support protocols at $100 (preferred option). The Tasso+ kit provides all approved blood panels required for TRT protocols.

Scale indicators14 records

Recent moves7 records

Expansion highlights6 records

MangoRx competitors and assessment

Company assessment

Direct peers

  • Keeps: DTC men's telehealth brand focused on hair loss treatment (Finasteride, Minoxidil). Directly comparable to MangoRx's Grow product line in both category and cash-pay model.
  • Ro (Roman): DTC men's telehealth platform historically focused on ED (Roman) and now spanning testosterone, hair, weight loss, and fertility. Directly comparable subscription model, condition-specific modules, and compounded offerings.
  • BlueChew: DTC telehealth platform specializing in compounded Sildenafil/Tadalafil chewable tablets for ED. Closely comparable business model and pharmacy-fulfillment approach to MangoRx's ED product line.
  • Hims & Hers Health: Largest direct-to-consumer telehealth platform for men's (and women's) health covering ED, hair loss, weight loss, and primary care. Closest direct competitor with public-comparable scale and a similar cash-pay subscription model.

Broad incumbents

  • Teladoc Health: Largest US telehealth incumbent offering virtual care across many specialties. Overlaps MangoRx at the telehealth delivery mechanism and provider network layer, though MangoRx is more DTC-focused.
  • GoodRx: Public digital health platform providing telehealth and prescription drug discounts. Broader incumbent that competes with MangoRx on cash-pay prescription affordability and online pharmacy access.

Emerging players

  • LifeMD: DTC telehealth company offering men's hormone therapy, weight management, and primary care with subscription programs. Comparable cash-pay telehealth model and category breadth.
  • Alpha Male Plus / Hone Health: DTC men's hormone optimization and TRT telehealth platform with at-home diagnostics. Directly comparable to MangoRx's TRT offering and similar subscription pricing model.
  • Vault Health: Telehealth platform offering testosterone replacement therapy and men's hormone optimization with at-home diagnostics. Closely comparable to MangoRx's TRT/Prime program with similar clinical workflow.
  • PeterMD: Men's telehealth brand offering ED, testosterone, and hair loss treatments via cash-pay subscription. Comparable niche DTC men's health positioning but smaller scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

MangoRx compliance and trust

Trust signal

Compliance2 records

MangoRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MangoRx leadership team

Management profile

Number of profiles

Profiles1 record

MangoRx subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

MangoRx funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MangoRx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MangoRx

What does MangoRx do?

MangoRx operates a 100% online men's telehealth platform that connects individual male patients with licensed U.S. medical providers via online questionnaires and consultations, then dispenses personalized compounded prescription medications through an in-network pharmacy shipped directly to the patient's home. The product portfolio centers on proprietary oral dissolving tablet (ODT) formulations across erectile dysfunction, testosterone replacement, hair loss, weight management, and athletic performance, supplemented by telehealth-mediated access to branded GLP-1 medications (Zepbound, Wegovy).

Is MangoRx a public or private company?

MangoRx is a public company. It is classified as public and is currently operating.

When was MangoRx founded?

MangoRx was founded in 2021. It employs 1 to 10 people.

Where is MangoRx based?

MangoRx is headquartered in Dallas, United States, in the North America region.

How does MangoRx make money?

Seven revenue lines are on record. Testosterone Replacement Therapy (TRT) Program is the primary driver. The others are erectile Dysfunction Medications (Mango – Sildenafil, Tadalafil, MangoMax), pump (Tadalafil + Agmatine Sulfate), grow Hair Loss Treatment, slim Weight Loss (Semaglutide ODT), GLP-1 Weight Management Programs (MangoRx Direct & PeachesRx Direct) and digital Asset Treasury Strategy.

Who are MangoRx's main competitors?

Direct peers on record are Keeps, Ro (Roman), BlueChew and Hims & Hers Health. Broad incumbents are Teladoc Health and GoodRx. Emerging players are LifeMD, Alpha Male Plus / Hone Health, Vault Health and PeterMD.

Does MangoRx have an API?

No public API is recorded for MangoRx.

What industry is MangoRx in?

MangoRx's product category is Men's Telehealth. Its primary akta.pro industry code is HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription), with a secondary code of HLALAIAJ, Men’s Health Prescribing + Pharmacy Delivery Platforms. Its NAICS code is 6213 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American Banking and Market NewsAlignment Healthcare (NASDAQ:ALHC) and Mangoceuticals (NASDAQ:MGRX) Critical SurveyAlignment Healthcare and Mangoceuticals are compared on valuation, earnings, and analyst ratings. Alignment Healthcare has higher revenue and earnings, while Mangoceuticals trades at a lower price-to-earnings ratio. Analysts rate Alignment Healthcare more favorably with a consensus price target of $14.00.GlobeNewswireMangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy DevelopmentNuclea Energy, Mangoceuticals' merger partner, signed an MOU with Utah's Office of Energy Development to explore siting a nuclear test reactor at the Utah San Rafael Energy Lab. The partnership aims to advance the Morpheus microreactor toward demonstration and deployment, with engagement from the DOE and NRC. Completion of the business combination remains subject to customary closing conditions.GlobeNewswireMangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business CombinationMangoceuticals received an 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement, with a deadline of February 1, 2027. The company continues its business combination with Nuclea Energy, which develops the Morpheus microreactor. Mangoceuticals plans to take necessary actions, including a reverse stock split, to regain compliance.The Manila TimesMangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment ProgramMangoceuticals Inc., a telemedicine company focused on men's health through its MangoRx brand, announced strong initial results from its newly launched $99/month injectable Testosterone Replacement Therapy program, with month-over-month sales growth of 336% since the mid-December launch and a 54% reduction in customer acquisition costs. The company stated it expects TRT to be its primary growth driver going forward as it expands beyond its current offerings to become a more comprehensive men's health and wellness platform. The announcement referenced market data projecting the global TRT market at approximately $2.11-2.2 billion in 2025 with a 3.9% compound annual growth rate.BenzingaMangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally? - Mangoceuticals (NASDAQ:MGRX)Mangoceuticals Inc (NASDAQ:MGRX) shares surged approximately 42% on Friday following the company's report of strong momentum for its $99-per-month injectable testosterone replacement therapy (TRT) program. Since launching in mid-December, month-over-month sales for the injectable TRT program climbed 336%, while customer acquisition costs fell 54%, with management expecting TRT to be the primary growth driver for its MangoRx telehealth platform. The company cited industry research valuing the global TRT market at $2.11 billion to $2.2 billion in 2025.GlobeNewswireMangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment ProgramMangoceuticals, Inc. (NASDAQ: MGRX) announced the initial success of its new injectable Testosterone Replacement Therapy (TRT) program priced at $99 per month, which has seen a 336% increase in sales and a 54% reduction in customer acquisition costs since mid-December. The company attributes this growth to increasing demand for TRT and its optimized telehealth platform, with plans to expand its offerings in men’s health and wellness.Stock TitanMangoceuticals raises $2.5M in registered direct, private dealsMangoceuticals, Inc., a health and wellness company focused on men's health telemedicine products under the MangoRx brand, has entered into definitive agreements with institutional investors to raise approximately $2.5 million through a registered direct offering and concurrent private placement. The transactions involved the sale of 1,930,502 Common Units (or Pre-Funded Units) at $1.295 per unit, with accompanying warrants exercisable at $1.42 per share, expected to close on or about December 19, 2025. Aegis Capital Corp. acted as the exclusive placement agent for the offerings, with net proceeds designated for general corporate purposes and working capital.GlobeNewswireMangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations PatentMangoceuticals, Inc. acquired patent WO 2023/086647 for mushroom-derived compositions, including Cordyceps, Reishi, and Lion's Mane. The company plans to develop wellness products like dietary supplements and functional foods, with planned cognitive and stress resilience formulas. The global functional mushroom market is projected to grow from $32.41B to $48.59B by 2029.GlobeNewswireMangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock SplitMangoceuticals, Inc. launched an investigation into potential stock manipulation following its October 16, 2024 reverse stock split, citing irregular trading and a DTC request for 213,327 shares. The request represents about 9% of outstanding shares, and CEO Jacob Cohen denied the request pending the investigation.